Q32 Bio (QTTB) Current Assets (2017 - 2026)

Q32 Bio has reported Current Assets for 10 years, with the latest figure at $57.2 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 16.65% year-over-year to $57.2 million; the trailing twelve-month figure through Mar 2026 stood at $57.2 million (down 16.65% YoY), and the FY2025 full-year result was $55.0 million, down 32.77% from the prior year.
• Current Assets for Q1 2026 stood at $57.2 million, up from $55.0 million in the prior quarter.
• The five-year high for Current Assets was $262.4 million in Q1 2022, with the low at $28.7 million in Q4 2023.
• Average Current Assets over 5 years is $119.5 million, with a median of $106.6 million recorded in 2023.
• Year-over-year, Current Assets plunged 84.14% in 2023 and surged 185.13% in 2024.
• Tracing QTTB's Current Assets over 5 years: stood at $181.0 million in 2022, then sank by 84.14% to $28.7 million in 2023, then surged by 185.13% to $81.9 million in 2024, then sank by 32.77% to $55.0 million in 2025, then advanced by 3.91% to $57.2 million in 2026.
• The last three Current Assets figures came in at $57.2 million (Q1 2026), $55.0 million (Q4 2025), and $50.8 million (Q3 2025), per Business Quant data.

Peer Comparison